London Daily

Focus on the big picture.
Thursday, Oct 16, 2025

EU export ban would delay UK Covid vaccine drive by two months

EU export ban would delay UK Covid vaccine drive by two months

Exclusive: Halting distribution would hit Britain badly but not significantly help EU, analysis finds
Britain’s Covid vaccine programme faces a two-month delay in the event of an EU export ban, derailing the government’s plans to reopen the economy this summer, an analysis for the Guardian reveals.

A ban, due to be debated by leaders of the 27 EU member states on Thursday, would badly stall the UK vaccination effort, and would be likely to force the government to extend restrictions on people’s lives.

It would not, however, provide a significant boost to EU member states’ troubled programmes, according to a report by the data analytics company Airfinity.

The comparatively small number of doses that would be kept within the bloc would speed up the full vaccination of every adult in the EU by “just over a week”, the research suggests.

On Sunday, the defence secretary, Ben Wallace, said the EU’s reputation was at stake as the 27 heads of state and government prepare to make their decision, warning that “the world is watching”.

“If contracts get broken, and undertakings, that is a very damaging thing to happen for a trading bloc that prides itself on the rule of law,” he told Sky News. “It is counterproductive because the one thing we know about vaccine production and manufacture is that it is collaborative.

“They would undermine not only their own citizens’ chances of having a proper vaccine programme, but also many other countries around the world, with the reputational damage for the EU which they would find very hard to change over the short term.”

The European commission president, Ursula von der Leyen, said last week that the EU was considering “all options” and ready to introduce emergency controls on vaccine production and distribution to deal with the “crisis of the century”.

The 27 heads of state and government will discuss the next steps on Thursday via video conference, amid growing concerns over a third wave of coronavirus infections on the continent. Plans to meet in person were cancelled on Sunday in light of a rise in infections.

France and Germany have privately spoken in support of activating article 122 of the EU’s treaty, last used in the 1970s oil crisis, allowing the bloc to take emergency measures to control the distribution of essential goods.

The EU commissioner for financial services, Mairead McGuinness, said on Sunday: “European citizens are growing angry and upset at the fact that the vaccine rollout has not happened as rapidly as we had anticipated.”

The EU member states had administered 10.4 vaccine doses per 100 people as of Saturday, compared with the 42.7 jabs administered per 100 in the UK.

About 10m vaccine doses have been exported from plants in EU member states to the UK, largely by Pfizer/BioNTech. The UK is waiting on around 30m more Pfizer doses and 30m from Johnson & Johnson – although only some of those had been expected to be delivered by the end of the summer.

The UK government was until the last fortnight on course to beat its target of delivering a first vaccine dose to every adult in the UK by the end of July by over six weeks, according to Airfinity.

A recent supply problem with AstraZeneca’s facility in India is expected to set back the pace of vaccination by two weeks, from 10 June to 23 June.

But the imposition of an export ban on doses of the Pfizer/BioNTech vaccine produced in Belgium and Germany, by far the largest export to the UK, would delay every adult receiving a first jab until 5 August, according to Airfinity.

A ban on all exports of vaccines due for distribution, including those from Moderna and Johnson & Johnson, would delay reaching that target to 27 August, the analysis commissioned by the Guardian further suggests.

Rasmus Bech Hansen, the chief executive of Airfinity, said: “Export bans are a lose-lose situation and threaten the global production scale-up.

“The imposition of a ban would mean the EU has marginally more doses short-term, but it won’t fundamentally change its vaccine availability, and the EU could soon be dependent on vaccine imports.

“A ban poses a significant risk for the UK and any potential UK retaliation on sub-ingredients would harm not only the EU and UK but the world, as it will significantly slow overall production.”

Airfinity’s estimate is based on how long it would take the UK to give at least one dose to 75% of its population, equivalent to an uptake of more than 95% of adults.

The EU has set itself the goal of fully vaccinating 70% of the population by the end of the summer.

According to Airfinity, the EU is on target for full vaccination of 75% of the population by 31 August despite its current difficulties, including the lack of supply from AstraZeneca.

Their analysis suggests that should the EU “keep and use the doses meant for the UK it would only bring them forward by just over a week [19 August], as their collective population is much greater”.

The commission and its member state governments have been enraged by the failure of AstraZeneca to deliver the promised 120m doses of its vaccine this quarter while it has continued to fulfil its contractual obligations with the UK government.

The company has pointed to the upfront funding provided for its collaboration with Oxford University by the UK government, and its company policy of creating bespoke supply chains for the EU and the UK.

AstraZeneca exports very few doses from EU plants to the UK but the commission is taking a keen interest in jabs and components made in the company’s Dutch facility. Sources have suggested that the commission could, in the first instance, act to block exports from there if a request is made.
Newsletter

Related Articles

0:00
0:00
Close
Australia’s Wedgetail Spies Aid NATO Response as Russian MiGs Breach Estonian Airspace
McGowan Urges Chalmers to Cut Spending Over Tax Hike to Close $20 Billion Budget Gap
Victoria Orders Review of Transgender Prison Placement Amid Safety Concerns for Female Inmates
U.S. Treasury Mobilises New $20 Billion Debt Facility to Stabilise Argentina
French Business Leaders Decry Budget as Macron’s Pro-Enterprise Promise Undermined
Trump Claims Modi Pledged India Would End Russian Oil Imports Amid U.S. Tariff Pressure
Surging AI Startup Valuations Fuel Bubble Concerns Among Top Investors
Australian Punter Archie Wilson Tears Up During Nebraska Press Conference, Sparking Conversation on Male Vulnerability
Australia Confirms U.S. Access to Upgraded Submarine Shipyard Under AUKUS Deal
“Firepower” Promised for Ukraine as NATO Ministers Meet — But U.S. Tomahawks Remain Undecided
Brands Confront New Dilemma as Extremists Adopt Fashion Labels
The Sydney Sweeney and Jeans Storm: “The Outcome Surpassed Our Wildest Dreams”
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
Dutch Government Seizes Chipmaker After U.S. Presses for Removal of Chinese CEO
Bessent Accuses China of Dragging Down Global Economy Amid New Trade Curbs
U.S. Revokes Visas of Foreign Nationals Who ‘Celebrated’ Charlie Kirk’s Assassination
AI and Cybersecurity at Forefront as GITEX Global 2025 Kicks Off in Dubai
DJI Loses Appeal to Remove Pentagon’s ‘Chinese Military Company’ Label
EU Deploys New Biometric Entry/Exit System: What Non-EU Travelers Must Know
Australian Prime Minister’s Private Number Exposed Through AI Contact Scraper
Ex-Microsoft Engineer Confirms Famous Windows XP Key Was Leaked Corporate License, Not a Hack
China’s lesson for the US: it takes more than chips to win the AI race
Australia Faces Demographic Risk as Fertility Falls to Record Low
California County Reinstates Mask Mandate in Health Facilities as Respiratory Illness Risk Rises
Israel and Hamas Agree to First Phase of Trump-Brokered Gaza Truce, Hostages to Be Freed
French Political Turmoil Elevates Marine Le Pen as Rassemblement National Poised for Power
China Unveils Sweeping Rare Earth Export Controls to Shield ‘National Security’
The Davos Set in Decline: Why the World Economic Forum’s Power Must Be Challenged
France: Less Than a Month After His Appointment, the New French Prime Minister Resigns
Hungarian Prime Minister Viktor Orbán stated that Hungary will not adopt the euro because the European Union is falling apart.
Sarah Mullally Becomes First Woman Appointed Archbishop of Canterbury
Mayor in western Germany in intensive care after stabbing
Australian government pays Deloitte nearly half a million dollars for a report built on fabricated quotes, fake citations, and AI-generated nonsense.
US Prosecutors Gained Legal Approval to Hack Telegram Servers
Macron Faces Intensifying Pressure to Resign or Trigger New Elections Amid France’s Political Turmoil
Standard Chartered Names Roberto Hoornweg as Sole Head of Corporate & Investment Banking
UK Asylum Housing Firm Faces Backlash Over £187 Million Profits and Poor Living Conditions
UK Police Crack Major Gang in Smuggling of up to 40,000 Stolen Phones to China
BYD’s UK Sales Soar Nearly Nine-Fold, Making Britain Its Biggest Market Outside China
Trump Proposes Farm Bailout from Tariff Revenues Amid Backlash from Other Industries
FIFA Accuses Malaysia of Forging Citizenship Documents, Suspends Seven Footballers
Latvia to Bar Tourist and Occasional Buses to Russia and Belarus Until 2026
A Dollar Coin Featuring Trump’s Portrait Expected to Be Issued Next Year
Australia Orders X to Block Murder Videos, Citing Online Safety and Public Exposure
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
×